Flosequinan, a new vasodilator: Systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure
- 31 December 1992
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 20 (7), 1542-1548
- https://doi.org/10.1016/0735-1097(92)90448-v
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Flosequinan: A vasodilator with positive inotropic activityAmerican Heart Journal, 1991
- Effect of flosequinan (BTS 49465) on myocardial oxygen consumptionAmerican Heart Journal, 1990
- Central and regional hemodynamic effects of flosequinan for congestive heart failureThe American Journal of Cardiology, 1989
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- In vivo validation of a thermodilution method to determine regional left ventricular blood flow in patients with coronary disease.Circulation, 1978
- Coronary sinus reflux. A source of error in the measurement of thermodilution coronary sinus flow.Circulation, 1978
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in ManCirculation, 1971